Financials

News Discussions Technicals Seasonals

Operating expenses (excl. COGS) of Conduit Pharmaceuticals Inc.

Annual data

2022

2023

TTM

‪‪−14.00 M‬‬

‪‪−10.50 M‬‬

‪‪−7.00 M‬‬

‪‪−3.50 M‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−12.80 M‬‬

‪‪−7.23 M‬‬

‪−130.06‬%

2023

‪‪−5.56 M‬‬

‪‪−2.40 M‬‬

‪−76.01‬%

2022

‪‪−3.16 M‬‬

‪‪−3.16 M‬‬

‪‪−72.03 K‬‬%

Quarterly data

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−6.00 M‬‬

‪‪−4.50 M‬‬

‪‪−3.00 M‬‬

‪‪−1.50 M‬‬

‪0.00‬

Period

Value

Change

Change %

Q3 '24

‪‪−5.81 M‬‬

‪‪−2.67 M‬‬

‪−84.90‬%

Q2 '24

‪‪−3.14 M‬‬

‪‪−185.00 K‬‬

‪−6.26‬%

Q1 '24

‪‪−2.96 M‬‬

‪‪−2.06 M‬‬

‪−230.17‬%

Q4 '23

‪‪−895.00 K‬‬

+‪‪174.00 K‬‬

+‪16.28‬%

Q3 '23

‪‪−1.07 M‬‬

‪‪−662.73 K‬‬

‪−163.13‬%

Q2 '23

‪‪−406.27 K‬‬

+‪‪101.14 K‬‬

+‪19.93‬%

Q1 '23

‪‪−507.41 K‬‬

‪‪−94.22 K‬‬

‪−22.80‬%

Q4 '22

‪‪−413.18 K‬‬

‪‪−166.82 K‬‬

‪−67.72‬%

Q3 '22

Q2 '22

Q1 '22